- Moxifloxacin demonstrated the highest risk of anaphylaxis within the fluoroquinolone class.
- Current guidelines recommend challenging patients with an alternative drug within the same class when hypersensitivity occurs.
- The study focused specifically on oral and intravenous formulations of levofloxacin, ciprofloxacin, and moxifloxacin.
- Women comprised 60.5% of fluoroquinolone-associated anaphylaxis cases.
- The mean age of affected patients was 55 years.
Fluoroquinolones vs Amoxicillin: Anaphylaxis Risk
Conexiant
February 12, 2025